TherapeuticsMD→Mayne Pharma
License/Asset Acquisition · Cash (license/asset) · MYX · announced Dec 30, 2022
Announced
Dec 30, 2022
Closed
Jan 3, 2023
Economics
Cash (license/asset)()
Pre-deal · pre-deal mark: 2022, year precision · rounding grid ±$100M · Mayne Pharma press release — TherapeuticsMD acquisition, 2023
$140M upfront license + $13.1M working capital + up to $30M milestones + 20-year royalties
Target
TherapeuticsMD
Reproductive Health · Clinical / therapeutic
HQ Boca Raton, FL · Founded 2008
Women's health hormone therapy — BIJUVA (bio-identical estradiol/progesterone for menopause), ANNOVERA (contraceptive vaginal ring), IMVEXXY (estradiol vaginal inserts); $153M total consideration
- Business Wire — TherapeuticsMD press release (Jan 3, 2023)
- SEC EDGAR — TherapeuticsMD 8-K (Dec 30, 2022)
Acquirer
Mayne Pharma (MYX)
Reproductive Health
HQ Melbourne, Australia
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Exclusive US rights to BIJUVA (menopause), ANNOVERA (contraception), and IMVEXXY (vaginal atrophy) — establishes Mayne Pharma in women's health hormone therapy
Evidence ladder
Secondary (press / IR)
Business Wire — TherapeuticsMD press release (Jan 3, 2023)
Primary (regulatory / filing)
SEC EDGAR 8-K (Dec 30, 2022)
SEC EDGAR filings (ticker locator)
Limitations
- $140M upfront license + $13.1M working capital + up to $30M milestones + 20-year royalties
- Pre-deal valuation sourced from: Mayne Pharma press release — TherapeuticsMD acquisition, 2023. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — TherapeuticsMD (Reproductive Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.